Inspection Readiness
Megan Clarke Megan Clarke

Inspection Readiness

The FDA's inspection approach is evolving toward risk-based oversight, continuous inspection readiness, increased use of remote assessments, and more targeted inspections. For pharmaceutical manufacturers, the days of preparing only when an audit is announced are rapidly disappearing. FDA is increasingly looking for evidence that quality systems are operating effectively every day, not just during an inspection.

Read More
The Future of GMP Training: Preparing Pharmaceutical Manufacturing Teams for a Digital Era
Megan Clarke Megan Clarke

The Future of GMP Training: Preparing Pharmaceutical Manufacturing Teams for a Digital Era

The pharmaceutical manufacturing industry is evolving rapidly. As facilities adopt automation, digital quality systems, AI-supported processes, and advanced manufacturing technologies, the expectations placed on today’s workforce are changing just as quickly. For pharmaceutical companies, training is no longer simply a compliance requirement — it has become a strategic investment in operational readiness, quality culture, and long-term success.

Read More
Why HACCP Matters in Pharmaceutical CQV: A Risk-Based Approach to Quality and Compliance
Megan Clarke Megan Clarke

Why HACCP Matters in Pharmaceutical CQV: A Risk-Based Approach to Quality and Compliance

In pharmaceutical manufacturing, Commissioning, Qualification, and Validation (CQV) are critical to ensuring systems perform as intended and consistently produce safe, high-quality products. As regulatory expectations continue to evolve toward risk-based, science-driven approaches, integrating Hazard Analysis and Critical Control Points (HACCP) into CQV strategies is no longer optional—it is a competitive and compliance necessity.

Read More
The Essentials of Good Project Management in Pharmaceutical CQV
Megan Clarke Megan Clarke

The Essentials of Good Project Management in Pharmaceutical CQV

In pharmaceutical manufacturing, Commissioning, Qualification, and Validation (CQV) projects live at the intersection of technical complexity, strict regulation, and aggressive timelines. Strong project management is not a “nice to have” — it is the backbone that keeps scope, quality, and compliance aligned while products move toward commercial readiness.

Read More
Pharmaceutical Manufacturing in 2026: Emerging GMP Trends Shaping the Future
Megan Clarke Megan Clarke

Pharmaceutical Manufacturing in 2026: Emerging GMP Trends Shaping the Future

The pharmaceutical industry continues to evolve at an unprecedented pace — driven by technological innovation, regulatory modernization, and shifting global expectations. In 2026, Good Manufacturing Practices (GMP) remain the cornerstone of quality, safety, and patient trust. However, the scope and interpretation of GMP compliance are changing rapidly. Today’s trends are not just regulatory checkboxes — they are strategic requirements for sustainable growth and operational excellence.

Read More